Low plasma adiponectin levels in obsessive-compulsive disorder

Journal of Affective Disorders

Volumn 117, Issue 3, 2009, Pages 205-207

  Atmaca, Murad ^a   Ustundag, Bilal ^a   Metin, Kerem ^a   Topuz, Mehtap ^a  

^a FIRAT UNIVERSITY   (Turkey)

Author keywords

Adiponectin; Glucose; OCD

Indexed keywords

ADIPONECTIN; GLUCOSE;

ADULT; ANALYSIS OF COVARIANCE; ARTICLE; BODY MASS; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HAMILTON SCALE; HUMAN; MALE; OBSESSIVE COMPULSIVE DISORDER; PATHOPHYSIOLOGY; PRIORITY JOURNAL;

ADIPONECTIN; ADULT; BLOOD GLUCOSE; BODY MASS INDEX; CARDIOVASCULAR DISEASES; FEMALE; HUMANS; MALE; OBSESSIVE-COMPULSIVE DISORDER; REFERENCE VALUES; RISK ASSESSMENT;

EID: 69249225554     PISSN: 01650327     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jad.2008.12.019     Document Type: Article

References (23)

1. Drevon C.A. Fatty acids and expression of adipokines. Biochim. Biophys. Acta 1740 (2005) 287-292
2. Goodman W.K., Price L.H., and Rasmussen S.A. The Yale-Brown Obsessive Compulsive Scale. Arch. Gen. Psychiatry 46 (1989) 1006-1016
3. Hamilton M. A rating scale for depression. J. Neurol. Neurosurg. Psychiatry 23 (1960) 56-62
4. Hara K., Horikoshi M., Yamauchi T., Yago H., Miyazaki O., Ebinuma H., et al. Measurement of the high-molecular weight form of adiponectin in plasma is useful for the prediction of insulin resistance and metabolic syndrome. Diabetes Care 29 (2005) 1357-1362 2006
5. Hillemacher T., Kraus T., Rauh J., Weiss J., Schanze A., Frieling H., Wilhelm J., Heberlein A., Gröschl M., Sperling W., Kornhuber J., and Bleich S. Role of appetite-regulating peptides in alcohol craving: an analysis in respect to subtypes and different consumption patterns in alcoholism. Alcohol., Clin. Exp. Res. 31 (2007) 950-954
6. Hillemacher T., Bleich S., Frieling H., Schanz A., Wilhelm J., Sperling W., Kornhuber J., and Kraus T. Evidence of an association of leptin serum levels and craving in alcohol dependence. Psychoneuroendocrinology 32 (2007) 87-90
7. Hillemacher T., Weinland C., Heberlein A., Gröschl M., Schanze A., Frieling H., Wilhelm J., Kornhuber J., and Bleich S. Increased levels of adiponectin and resistin in alcohol dependence-possible link to craving. Drug Alcohol Depend. 99 (2009) 333-337
8. Iacobellis G., Pistilli D., Gucciardo M., Leonetti F., Miraldi F., et al. Adiponectin expression in human epicardial adipose tissue in vivo is lower in patients with coronary artery disease. Cytokine 29 (2005) 251-255
9. Kadowaki T., and Yamauchi T. Adiponectin and adiponectin receptors. Endocr. Rev. 26 (2005) 439-451
10. Konuk N., Tekin I.O., Ozturk U., Atik L., Atasoy N., Bektas S., and Erdogan A. Plasma levels of tumor necrosis factor-alpha and interleukin-6 in obsessive compulsive disorder. Mediat. Inflamm. 65 (2007) 704
11. Kraus T., Reulbach U., Bayerlein K., Mugele B., Hillemacher T., Sperling W., Kornhuber J., and Bleich S. Leptin is associated with craving in females with alcoholism. Addict. Biol. 9 (2004) 213-219
12. Leo R., Di Lorenzo G., Tesauro M., Cola C., Fortuna E., Zanasi M., et al. Decreased plasma adiponectin concentration in major depression. Neurosci. Lett. 407 (2006) 211-213
13. Matsuzawa Y. The metabolic syndrome and adipocytokines. FEBS Lett. 580 (2006) 2917-2921
14. Mössner R., Heils A., Stöber G., Okladnova O., Daniel S., and Lesch K.-P. Enhancement of serotonin transporter function by tumor necrosis factor alpha but not by interleukin-6. Neurochem. Int. 33 (1998) 251-254
15. Narita K., Murata T., Takahashi T., Kosaka H., Omata N., and Wada Y. Plasma levels of adiponectin and tumor necrosis factor-alpha in patients with remitted major depression receiving long-term maintenance antidepressant therapy. Prog. Neuro-psychopharmacol. Biol. Psychiatry 30 (2006) 1159-1162
16. Schiepers J., Wichers M.C., and Maes M. Cytokines and major depression. Prog. Neuro-psychopharmacol. Biol. Psychiatry 29 (2005) 201-217
17. Shimada K., Miyazaki T., and Daida H. Adiponectin and atherosclerotic disease. Clin. Chim. Acta 344 (2004) 1-12
18. Taylor C.B., Youngblood M.E., Catellier D., Veith R.C., Carney R.M., et al. Effects of antidepressant medication on morbidity and mortality in depressed patients after myocardial infarction. Arch. Gen. Psychiatry 62 (2005) 792-798
19. Tentolouris C., Tousoulis D., Antoniades C., Bosinakou E., Kotsopoulou M., Trikas A., et al. Endothelial function and proinflammatory cytokines in patients with ischemic heart disease and dilated cardiomyopathy. Int. J. Cardiol. 94 (2004) 301-305
20. Tsao T.S., Lodish H.F., and Fruebis J. ACRP30, a new hormone controlling fat and glucose metabolism. Eur. J. Pharmacol. 440 (2002) 213-221
21. Weber-Hamann B., Kratzsch J., Kopf D., Lederbogen F., Gilles M., Heuser I., and Deuschle M. Resistin and adiponectin in major depression: the association with free cortisol and effects of antidepressant treatment. J. Psychiatr. Res. 41 (2007) 344-350
22. Xia Z., DePierre J.W., and Nassberger L. Tricyclic antidepressants inhibit IL-6, IL-1 beta and TNF-alpha release in human blood monocytes and IL-2 and interferon-gamma in T cells. Immunopharmacology 34 (1996) 27-37
23. Youn B.S., Yu K.Y., Park H.J., Lee N.S., Min S.S., et al. Plasma resistin concentrations measured by enzyme-linked immunosorbent assay using a newly developed monoclonal antibody are elevated in individuals with type 2 diabetes mellitus. J. Clin. Endocrinol. Metab. 89 (2004) 150-156